Law360, New York (June 11, 2012, 8:19 PM ET) -- A RyMed Technology Inc. catheter component does not infringe a patent held by rival Laboratoires Pharmaceutiques Vygon, a Tennessee federal judge ruled Thursday, following a reexamination by the U.S. Patent and Trademark Office.
The USPTO, which issued a reexamination certificate in May, invalidated all but one claim of the patent Vygon alleged the Franklin, Tenn.-based RyMed had infringed by manufacturing the component, U.S. District Judge Kevin Sharp of Tennessee federal court said. The remaining claim was not reviewed as part of the reexamination.
Vygon, which is...
RyMed Wins Catheter Row After USPTO Nixes Rival's Patent
To view the full article, take a free trial now.
